Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs at the 36th European College of Neuropsychopharmacology (ECNP) Congress
Stock Information for Relmada Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.